By Saleem Ali, MD
The FDA has issued new warnings regarding the use of high dose Simvastatin. The FDA is now recommending that the 80mg dose only be used in patients who have been taking that dosage for at least 12 …
Category: Pharmacology
Clinical Correlations
Resveratrol: The Modern Fountain of Youth?
February 9, 2011
By Lee Rasamny
Faculty Peer Reviewed
For thousands of years, humans have been fascinated with the idea of slowing and perhaps even reversing the process of aging. From Ponce de León to modern research …
The Polymyxins: Why am I using them all the time, and what are they?
December 8, 2010
By Jon-Emile S Kenny
Faculty Peer Reviewed
A 65-year-old female with locally advanced rectal cancer is admitted to the ICU, hypotensive and febrile. Her PICC line is removed and …
Kayexalate: What is it and does it work?
December 1, 2010
By Todd Cutler, MD
Faculty Peer Reviewed
A 62-year-old male is hospitalized with an acute congestive heart failure exacerbation. On hospital day three, the patient’s symptoms have significantly …
Proton Pump Inhibitors 2.0
November 26, 2010
By Mary C. Whitman, MD
Faculty Peer Reviewed
Proton pump inhibitors (PPIs) are generally considered “safe†medications[1] and are prescribed to over 100 million patients per year for a variety of indications, often …
Clopidogrel (Plavix®) and Proton Pump Inhibitors: An Update on the Potential Drug Interaction
July 28, 2010
By Antony Q. Pham, Pharm.D. and Reena M. Tejura, Pharm.D.
Faculty Peer Reviewed
Recent publications have described a potential drug interaction between clopidogrel (Plavix®) and proton pump inhibitors (PPIs). …
Antimicrobial Therapy Geared at Pseudomonas aeruginosa for Bronchiectasis
April 7, 2010
Diana Hubulashvili, Pharm.D.
Edited by Tania Ahuja, Pharm.D., BCPS
Read More
When Clopidogrel Fails…
March 10, 2010
Marisa Mizus
Faculty peer reviewed
Clopidogrel (Plavix) has been the standard of care for patients with coronary artery disease following percutaneous coronary intervention (PCI) for the past decade. Although …